STALEY CAPITAL ADVISERS’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.19M | Sell |
14,385
-1,700
| -11% | -$141K | 0.05% | 105 |
|
|
2025
Q1 | $1.3M | Sell |
16,085
-1,930
| -11% | -$157K | 0.06% | 98 |
|
|
2024
Q4 | $1.62M | Buy |
18,015
+50
| +0.3% | +$4.5K | 0.07% | 89 |
|
|
2024
Q3 | $1.77M | Sell |
17,965
-550
| -3% | -$54.3K | 0.08% | 82 |
|
|
2024
Q2 | $1.72M | Buy |
18,515
+300
| +2% | +$27.8K | 0.08% | 83 |
|
|
2024
Q1 | $1.73M | Sell |
18,215
-100
| -0.5% | -$9.49K | 0.08% | 79 |
|
|
2023
Q4 | $1.64M | Sell |
18,315
-28,770
| -61% | -$2.57M | 0.08% | 83 |
|
|
2023
Q3 | $3.44M | Buy |
47,085
+250
| +0.5% | +$18.3K | 0.19% | 60 |
|
|
2023
Q2 | $3.9M | Sell |
46,835
-1,185
| -2% | -$98.6K | 0.21% | 58 |
|
|
2023
Q1 | $3.66M | Sell |
48,020
-610
| -1% | -$46.5K | 0.2% | 58 |
|
|
2022
Q4 | $4.04M | Sell |
48,630
-19,152
| -28% | -$1.59M | 0.24% | 56 |
|
|
2022
Q3 | $5.38M | Buy |
67,782
+11,300
| +20% | +$896K | 0.34% | 50 |
|
|
2022
Q2 | $4.2M | Buy |
56,482
+15,640
| +38% | +$1.16M | 0.25% | 55 |
|
|
2022
Q1 | $3.67M | Buy |
+40,842
| New | +$3.67M | 0.19% | 63 |
|